Neurobiological bases for the relation between sleep and depression

Sleep Medicine Reviews

Volumn 6, Issue 5, 2002, Pages 341-351

  Adrien, Joëlle ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Autoreceptors; Depression; Desensitization; Serotonin; Serotonin reuptake blocker; Sleep; Somatodendritic 5 HT1A

Indexed keywords

AMINEPTINE; ANTIDEPRESSANT AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; MONOAMINE OXIDASE INHIBITOR; PINDOLOL; SEROTONIN; SEROTONIN 1 AGONIST; SEROTONIN 1 ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 2 ANTAGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; BRAIN DERIVED NEUROTROPHIC FACTOR;

BRAIN STEM; DEPRESSION; DRUG MECHANISM; HUMAN; INSOMNIA; MOOD; NEUROBIOLOGY; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; RECEPTOR DOWN REGULATION; REM SLEEP; REVIEW; SEROTONINERGIC SYSTEM; SLEEP; WAKEFULNESS; BRAIN; MAJOR DEPRESSION; METABOLISM; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; SLEEP DISORDER; SYNAPTIC TRANSMISSION;

BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; HUMANS; SEROTONIN; SLEEP DISORDERS; SLEEP, REM; SYNAPTIC TRANSMISSION; WAKEFULNESS;

EID: 0036824736     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1087-0792(01)90200-X     Document Type: Review

References (78)

1. Dahlström A, Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in cell bodies of brain stem neurons. Acta Physiol Scand 1964;232:SI-S55.
2. Tork I. Anatomy of the serotoninergic system. Ann NY Acad Sci 1990; 600: 9-35.
3. Pineyro G, Blier P. Autoregulation of serotonin neurons: role on antidepressant drug action. Pharmacol Rev 1999; 51: 533-591.
4. VanderMaelen CP, Aghajanian GK. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res 1983; 289: 109-119.
5. Adrien J. The serotoninergic system and sleep-wakefulness regulations. In: Kales A (ed) Pharmacology of sleep, Handbook of Experimental Pharmacology, Berlin: Springer-Verlag 1995; 116: 91-116.
6. Trulson MH, Jacobs BL. Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Res 1979; 163: 135-150.
7. Guzmàn-Marin R, Alam MN, Szymuziak R, Drucker-Colin R, Gong H, McGinty D. Discharge modulation of rat dorsal raphe neurons during sleep and waking: effects of preoptic/basal forebrain warming. Brain Res 2000; 875: 23-34.
8. Portas CM, Bjorvatn B, Ursin R. Serotonin and the sleep/wake cycle: special emphasis on microdialysis studies. Progr Neurobiol 2000; 60: 13-35.
9. 1A agonist, on sleep-wakefulness cycles: probable post-synaptic action. J Sleep Res 1993; 2: 103-109.
10. Gervasoni D, Peyron C, Rampon C, Barbagli B, Chouvet G, Urbain N et al. Role and origin of the GABAergic innervation of Dorsal Raphe serotoninergic neurons. J Neurosci 2000; 20: 4217-4225.
11. Ursin R. Serotonin and sleep. Sleep Med Rev 2002; 6: 55-67.
12. 2 receptors in the regulation of sleep and wakefulness in the rat. Psychopharmacology 1989; 97: 436-442.
13. 1B knock-out mice. J Neuroscience 1999; 19: 3204-3212.
14. 1A knock-out mice. J Neurosci 2002; (in press).
15. Sakai C, Crochet S. Role of dorsal raphe neurons in paradoxical sleep generation in the cat: no evidence for a serotonergic mechanism. Eur J Neurosci 2001; 13: 103-112.
16. Horner R, Sanford L, Annis A, Pack A, Morrison A. Serotonin at the laterodorsal tegmental nucleus suppresses rapid eye movement sleep in freely behaving rats. J Neurosci 1997; 17: 7541-7552.
17. Thakkar M, Strecker R, McCarley R. Behavioral state control through differential serotoninergic inhibition in the mesopontine cholinergic nuclei: a simultaneous unit recording and microdialysis study. J Neurosci 1998; 18: 5490-5497.
18. Kupfer DJ. REM latency: a psychobiological marker for primary depressive disease. Biol Psychiatry 1975; 11: 159-174.
19. Benca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and psychiatric disorders: a meta-analysis. Arch Gen Psychiatry 1992; 49: 651-668.
20. International Classification of Sleep Disorders. Diagnostic and Coding Manual. American Sleep Disorders Association, Rochester, MN, 1990.
21. Vogel GW, Buffenstein A, Minter K, Hennessey A. Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev 1990; 14: 49-63.
22. Steriade M, McCarley R. REM sleep as a biological rhythm. In: Steriade M & Mc Carley R (eds) Brainstem control of wakefulness and sleep, New York: Plenum Press 1990: 363-393.
23. Gillin JC, Sutton L, Ruiz C, Kelsoe J, Dupont RM, Darko D et al. The cholinergic rapid eye movement induction test with arecoline in depression. Arch Gen Psychiatry 1991; 48: 264-270.
24. Maes M, Meltzer HY. The serotonin hypothesis of major depression. In: Bloom FE & Kupfer DJ (eds) Psychopharmacology: The fourth generation of progress, New York: Raven Press 1995:933-944.
25. Lauriello J, Kenny WM, Sutton L, Golshan S, Ruiz C, Kelsoe J et al. The cholinergic REM sleep induction test with pilocarpine in midly depresses patients and normal controls. Biol Psychiatry 1993; 33: 33-39.
26. Siefritz E, Gillin JC, Rapaport MH, Kelsoe JR, Bhatti T, Stahl SM. Sleep electroencephalographic response to muscarinic and serotonin1A receptor probes in patients with major depression and in normal controls. Biol Psychiatry 1998; 44: 21-33.
27. Adrien J, Dugovic C, Martin P. Sleep-wakefulness patterns in the helpless rat. Physiol Behav 1991; 49: 257-262.
28. Vogel GW, Neill D, Kors D, Hagler M. REM sleep abnormalities in a new animal model of endogenous depression. Neurosci Biobehav Rev 1990; 14: 77-83.
29. Dugovic C, Maccari S, Weibel L, Turek FW, Van Reeth O. High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. J Neurosci 1999; 19: 8656-8664.
30. Boutrel B, Pardon MC, Joubert C, Barden N, Hamon M, Cohen-Salmon C et al. Different courses of Paradoxical Sleep (PS) rebound after PS deprivation or immobilization stress. J Sleep Res 2000; 9 (Suppl. 1): 25.
31. Pflug B, Tölle R. Disturbance of the 24-hour-rythm in endogenous depression and the treatment of endogenous depression by sleep deprivation. Int Pharmacopsychiatry 1971; 6: 187-196.
32. Wu JC, Bunney WE. The biological basis of an antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry 1990; 147: 14-21.
33. Wirz-Justice A, Van den Hoofdakker RH. Sleep deprivation in depression: what do we know, where do we go? Biol Psychiatry 1999; 46: 445-453.
34. Southmayd SE, Michela MD, Cairns J, Delva NJ, Letemendia FJ, Waldron JJ. Sleep deprivation in depression; pattern of relapse and characteristics of preceding sleep. Biol Psychiatry 1990; 28: 979-988.
35. Vogel GW, Vogel F, Mc Abee RS, Thurmond AJ. Improvement of depression by REM sleep deprivation, new findings and a theory. Arch Gen Psychiatry 1980; 37: 247-253.
36. Van den Hoofdakker RH. Total sleep deprivation: clinical and theoretical aspects. In: Honig AV & Praag HM (eds) Depression: Neurobiological, psychopathogical and therapeutic advances, Chichester: John Wiley & Sons 1997: 564-589.
37. Adrien J. Antidepressant-like effects of paradoxical sleep deprivation in the learned helplessness paradigm. J Sleep Res 1992; I (Suppl. 1): 2.
38. Koolhass JM, Hermann PM, Kemperman C, Bohus B, Van den Hoofdakker RH, Beersma DGM. Single social defeat in male rats induces a gradual but long lasting behavioural change: a model of depression. Neurosci Res Comm 1990; 7: 35-41.
39. Prathiba J, Kumar KB, Karanth KS. Effects of REM sleep deprivation on cholinergic receptor sensitivity and passive avoidance behaviour in chlomipramine model of depression. Brain Res 2000; 867: 243-245.
40. Janowsky DS, Davis JM, El-Yousef MK, Sekerke HJ. A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1972; 2: 632-635.
41. Kapitany T, Schindl M, Schindler SD, Hesselmann B, Fureder T, Barnas C et al. The citalopram challenge test in patients with major depression and healthy controls. Psychiatry Res 1999; 88: 75-88.
42. Staley JK, Malison RT, Innis RB. Imaging of the serotoninergic system: interactions of neuroanatomical and functional abnormalities of depression. Biol Psychiatry 1998; 44: 534-549.
43. Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 1998; 18: 7394-7401.
44. Ogilvie A, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 1996; 347: 731-737.
45. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Arch Gen Psychiatry 1990; 47: 411-418.
46. Moore P, Landholt H, Seifritz E, Clark C, Bhatti T, Kelsoe J et al. Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology 2000; 23: 601-622.
47. Maudhuit C, Prévot E, Dangoumau L, Martin P, Hamon M, Adrien J. Antidepressant treatment in helpless rats: Effect on the electrophysiological activity of raphe dorsalis serotoninergic neurons. Psychopharmacology 1997; 130: 269-275.
48. Blier P, de Montigny C, Chaput Y. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol 1987; 7: 24S-35S.
49. Bel N, Artigas F. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 1993; 15: 243-45.
50. , Hjorth S, Bengtsson HJ, Kullberg A, Carlzon D, Peilot H, Auerbach SB. Serotonin autoreceptor function and antidepressant drug action. J Psychopharmacol 2000; 14: 177-185.
51. Chaput Y, Blier P, de Montigny C. Acute and long-term effects of antidepressant serotonin (5-HT) reuptake blockers on the efficacy of 5-HT neurotransmission: electrophysiological studies in the rat central nervous system. Adv Biol Psychiatry 1988; 17: 1-17.
52. 1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J Pharm Exp Ther 1994; 268:1432-1443.
53. Maudhuit C, Hamon M, Adrien J. Effects of chronic treatment with zimelidine and REM sleep deprivation on the regulation of raphe neuronal activity in a rat model of depression. Psychopharmacology 1996; 124: 267-274.
54. Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 1994; 51: 248-251.
55. Blier P, Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Pharmacol 1995; 15: 217-222.
56. 1A antagonists. Trends Neuro Sci 1996; 19: 378-383.
57. Dannon PN, Sasson Y, Hirschmann S, Ianeu I, Grunhaus LJ, Zohar J. Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial. Eur Neuropsychopharmacol 2000; 10: 165-169.
58. Montgomery SA. New developments in the treatment of depression. J Clin Psychopharmacol 1999, 60 (Suppl. I): 10-15.
59. 1A receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-(II)C]WAY-100635. Nucl Med Biol 2000; 27: 509-513.
60. Berman RM, Anand A, Cappiello A, Miller HL, Hu XS, Oren DA et al. The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial. Biol Psychiatry 1999; 45: 1170-1177.
61. Rasanen P, Hakko H, Tihonen J. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients. J Clin Psychopharmacol 1999; 19: 383-384.
62. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M. Polymorphism within the promotor of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 1998; 3: 508-511.
63. Benedetti F, Seretti A, Colombo C, Campori E, Barbini B, di Bella D et al. Infuence of a functional polymorphism within the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am J Psychiatry 1999; 156: 1450-1452.
64. Siefritz E, Muller MJ, Annen O, Nil R, Hatzinger M, Hemmeter U et al. Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects. J Psychiatr Res 1997; 31: 543-554.
65. Maudhuit C, Jolas T, Chastanet M, Hamon M, Adrien J. Reduced inhibitory potency of 5-HT reuptake blockers on central serotoninergic neurons in rats selectively deprived of rapid eye movement sleep. Biol Psychiatry 1996; 40: 1000-1007.
66. Prévot E, Maudhuit C, Le Poul E, Hamon M, Adrien J. Sleep deprivation reduces the citalopram-induced inhibition of serotoninergic neuronal firing in the nucleus raphe dorsalis of the rat. J Sleep Res 1996; 5: 238-245.
67. Gardner JP, Fornal CA, Jacobs BL. Effects of sleep deprivation on serotoninergic neuronal activity in the dorsal raphe nucleus of the freely movint cat. Neuropsychopharmacology 1997; 17: 72-81.
68. Smeraldi E, Benedetti F, Barbini B, Campori E, Colombo C. Sustained antidepressant effect of sleep deprivation combined with pindolol in bipolar depression. A placebo-controlled trial. Neuropsychopharmacology 1999; 20: 380-385.
69. Benedetti F, Barbini B, Campori E, Colombo C, Smeraldi E. Dopamine agonist amineptine prevents the antidepressant effect of sleep deprivation. Psychiatry Res 1996; 65: 179-184.
70. Leibenluft E, Wehr TA. Is sleep deprivation useful in the treatment of depression? Am J Psychiatry 1992; 149: 159-168.
71. Benedetti F, Barbini B, Lucca A, Campori E, Colombo C, Smeraldi E. Sleep deprivation hastens the antidepressant action of fluoxetine. Eur Arch Psychiatry Clin Neurosci 1997; 247: 100-103.
72. Post RM, Weiss SR. Endogenous biochemical abnormalities in affective illness: therapeutic versus pathogenic. Biol Psychiatry 1992; 32: 469-484.
73. Ebert D, Berger M. Neurobiological similarities in antidepressant sleep deprivation and psychostimulant use: a psychostimulant theory of antidepressant sleep deprivation. Psychopharmacology 1998; 140: 1-10.
74. Giles DE, Kupfer DJ, Rush AJ, Roffwarg HP. Controlled comparison of electrophysiological sleep in families of probands with unipolar depression. Am J Psychiatry 1998; 155: 192-199.
75. Gillin JC. Are sleep disturbance risk factors for anxiety, depressive and addictive disorders? Acta Psychiatr Scand. (Suppl.) 1998; 393: 39-43
76. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989; 262: 1479-1484.
77. Benca RM. Consequences of insomnia and its therapies. J Clin Psychiatry 2001; 62 (Suppl. 10): 33-38.
78. Viot-Blanc V. To sleep more or to sleep less to get a better mood? J Sleep Res 1996; 5 (Suppl. I): 244.